Custom-designed plaque radiotherapy for nonresectable iris melanoma in 38 patients: Tumor control and ocular complications

American Journal of Ophthalmology

Volumn 135, Issue 5, 2003, Pages 648-656

  Shields, Carol L ^a,c,e,f   Naseripour, Masood ^a   Shields, Jerry A ^a,d   Freire, Jorge ^b   Cater, Jacqueline ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c Eye Tumor Research Foundation   (United States)

^d P K Intl Award Merit Retina Res   (United States)

^e 2001 Rosenthal Award Macula Soc ^*  (Spain)

^f WILLS EYE HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 125;

ADOLESCENT; ADULT; AGED; ANTERIOR EYE CHAMBER; ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; CATARACT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORNEA DISEASE; CORNEA EPITHELIUM; CORNEA NECROSIS; ENUCLEATION; EYE CANCER; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; INTRAOCULAR PRESSURE; IRIS TUMOR; KAPLAN MEIER METHOD; MALE; MELANOMA; METASTASIS; NECROSIS; NEOVASCULAR GLAUCOMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE; RECURRENT DISEASE; REGRESSION ANALYSIS; RETINOPATHY; SCHOOL CHILD; SCLERA DISEASE; TREATMENT OUTCOME; TUMOR RECURRENCE; TUMOR VOLUME; VISUAL ACUITY;

EID: 0037405493     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(02)02241-9     Document Type: Article

References (23)

1. Shields J.A., Shields C.L. Melanocytic tumors of the iris stroma. In: Intraocular tumors. A text and atlas. 1992;61-84 WB Saunders, Philadelphia.
2. Territo C., Shields C.L., Shields J.A., et al. Natural course of melanocytic tumors of the iris. Ophthalmology. 95:1988;1251-1255.
3. Jensen O.A. Malignant melanomas of the human uvea. Recent follow-up of cases in Denmark, 1943-1952. Acta Ophthalmol (Copenh). 48:1970;1113-1128.
4. Shields C.L., Shields J.A., Materin M., et al. Iris melanoma risk factors for metastasis in 169 consecutive patients . Ophthalmology. 108:2001;172-178.
5. Shields C.L., Materin M., Shields J.A., et al. Factors associated with elevated intraocular pressure in eyes with iris melanoma. Br J Ophthalmol. 85:2001;666-669.
6. Shields C.L., Shields J.A., DePotter P., et al. Treatment of nonresectable malignant iris tumors with custom designed plaque radiotherapy. Br J Ophthalmol. 79:1995;306-312.
7. Kaplan E., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481.
8. Lee E.T. Statistical methods for survival data analysis. 2nd ed:1992;258 Wiley and Sons, New York.
9. Shields J.A., Shields C.L., Donoso L.A. Management of posterior uveal melanoma. Surv Opthalmol. 36:1991;161-195.
10. Shields C.L., Shields J.A., Gunduz K., et al. Radiation therapy for uveal malignant melanoma. Ophthalmic Surg Lasers. 29:1998;397-409.
11. Shields J.A., Shields C.L. Management of posterior uveal melanoma. In: Atlas of intraocular tumors. 1999;113-140 Lippincott Williams and Wilkins, Philadelphia.
12. Gunduz K., Shields C.L., Shields J.A., et al. Radiation complications and tumor control after plaque radiotherapy of choroidal melanoma with macular involvement. Am J Ophthalmol. 127:1999;579-589.
13. DePotter P., Shields C.L., Shields J.A., et al. Plaque radiotherapy for juxtapapillary choroidal melanoma. Visual acuity and survival outcome. Arch Ophthalmol. 114:1996;1357-1365.
14. Gunduz K., Shields C.L., Shields J.A., et al. Plaque radiotherapy of uveal melanoma with predominant ciliary body involvement. Arch Ophthalmol. 117:1999;170-177.
15. Gunduz K., Shields C.L., Shields J.A., et al. Plaque radiotherapy for management of ciliary body and choroidal melanoma with extrascleral extension. Am J Ophthalmol. 130:2000;97-102.
16. Augsburger J.J., Schneider S., Freire J., Brady L.W. Survival following enucleation versus plaque radiotherapy in statistically matched subgroups of patients with choroidal melanomas results in patients treated between 1980 and 1987 . Graefe's Arch Clin Exp Ophthalmol. 237:1999;558-567.
17. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III initial mortality findings. COMS report no. 18 . Arch Ophthalmol. 119:2001;969-982.
18. DePotter P., Shields C.L., Shields J.A., et al. Impact of enucleation versus plaque radiotherapy in the management of juxtapapillary choroidal melanoma on patient survival. Br J Ophthalmol. 78:1994;109-114.
19. Shields C.L., Chao A., Shields J.A., et al. Combined plaque radiotherapy and transpupillary thermotherapy for choroidal melanoma in 270 consecutive patients. Arch Ophthalmol. 120:2002;933-940.
20. Shields C.L., Shields J.A., Cater J., et al. Plaque radiotherapy for uveal melanoma. Long-term visual outcome in 1106 patients. Arch Ophthalmol. 118:2000;1219-1228.
21. Gunduz K., Shields C.L., Shields J.A., et al. Radiation retinopathy following plaque radiotherapy of posterior uveal melanoma. Arch Ophthalmol. 117:1999;609-614.
22. Finger P.T. Plaque radiation therapy for malignant melanoma of the iris and ciliary body. Am J Ophthalmol. 132:2001;328-335.
23. Geisse L.J., Robertson D.M. Iris melanomas. Am J Ophthalmol. 99:1985;634-648.